SIGN-UP NOW! SIGN-UP NOW! Click to become a VoiceAmerica Member for Free!
Voiceamerica radio logo
voiceamerica-business radio logo
Apple logo Google Play Store Kindle store
The Ellis Martin Report

The Ellis Martin Report

Shows added weekly

December 09th 2015:Aging is a Disease that COULD be Cured in a Year!

Today on the program we’ll visit with Dr. William H. Andrews of Sierra Sciences with an unsponsored, not paid for segment discussing his research and successes in curing the disease of aging, leading to potential mortality. Are we just over one year away from this? Listen and learn as Ellis revisits with Dr. Andrews exactly 5 years to the day that his last interview on this program was conducted. Ellis also chats with Dr. Brad Thompson of sponsor Oncolytics Biotech trading as ONCY discussing a potential cancer cure and he’ll speak with Kenneth Efird of Nobilis Health trading as HLTH.

Share Email SHARE
Download PDF DOWNLOAD PDF
Get Code GET CODE

Tune in

Shows added weekly on VoiceAmerica Business Channel
EPISODE ON DEMAND
VIEW HOST PAGE

Featured Guests

Guest Image

Dr. William H Andrews

Dr. Andrews earned his Ph.D. in Molecular and Population Genetics at the University of Georgia in 1981. He was a Senior Scientist at Armos Corporation and Codon Corporation, Director of Molecular Biology at Codon and at Geron Corporation, and Director of Technology Development at EOS Biosciences. While Director of Molecular Biology at Geron Corporation from 1992 to 1997, Dr. Andrews was one of the principal discoverers of both the RNA and protein components of human telomerase and was awarded 2nd place as "National Inventor of the Year" in 1997 for this work. He is presently a named inventor on 35 US issued telomerase patents. Dr. Andrews is an avid runner and enjoys participating in ult
Read more
Guest Image

Dr. Brad Thompson

Chairman, President & Chief Executive Officer of Oncolytics Biotech, Inc. Dr. Thompson has held the positions of Chairman of the Board, President and Chief Executive Officer of Oncolytics Biotech Inc. since April 1999. He has provided leadership to various organizations within the biotechnology sector for more than twenty years. Prior to his role with Oncolytics, Dr. Thompson was the Chief Executive Officer of SYNSORB Biotech from 1994 to 1999. From 1983 to 1994, Dr. Thompson worked in a senior role at the Alberta Research Council. He is a current member and Emeritus Chairman of BIOTECanada and sits on the boards of various other biotechnology companies. He received his PhD from the Uni
Read more
Guest Image

Kenneth Efird

As a proven leader in marketing and operations, Kenneth D. Efird has been instrumental in leading organizational change. Joining Nobilis Healthcare Inc. in 2010 as Director of Clinical Operations, managing center operations and business development, his results-oriented approach has been influential in increasing revenues of $14 million in 2012 to an expected $74 million in 2014 . In 2013, Kenneth undertook development of an in-house marketing department that would both increase revenue through Direct to Consumer programs and decrease the expense of the current external marketing agency. In a little over a year, Northstar Healthcare has grown to a complete advertising agency, consisting
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
GPlus Facebook Twitter Linkedin Social Media
presspass-banner